DK157168C - Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid - Google Patents

Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid

Info

Publication number: DK157168C
Authority: DK; Denmark
Prior art keywords: diamindichloride; procedure; preparation; pharmaceutical preparations; preparations based
Prior art date: 1982-09-23

Application number

DK424383A

Other languages

English (en)

Other versions

DK424383A (da

DK424383D0 (da

DK157168B (da

Inventor

Gaetano Battelli

Diego Oldani

Alessandro Rigamonti

Original Assignee

Erba Carlo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-09-23

Filing date

1983-09-16

Publication date

1990-04-09

1983-09-16 Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa

1983-09-16 Publication of DK424383D0 publication Critical patent/DK424383D0/da

1984-03-24 Publication of DK424383A publication Critical patent/DK424383A/da

1989-11-20 Publication of DK157168B publication Critical patent/DK157168B/da

1990-04-09 Application granted granted Critical

1990-04-09 Publication of DK157168C publication Critical patent/DK157168C/da

Links

238000000034 method Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK424383A 1982-09-23 1983-09-16 Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid DK157168C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT23396/82A IT1153974B (it)	1982-09-23	1982-09-23	Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
IT2339682		1982-09-23

Publications (4)

Publication Number	Publication Date
DK424383D0 DK424383D0 (da)	1983-09-16
DK424383A DK424383A (da)	1984-03-24
DK157168B DK157168B (da)	1989-11-20
DK157168C true DK157168C (da)	1990-04-09

Family

ID=11206716

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK424383A DK157168C (da)	1982-09-23	1983-09-16	Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid

Country Status (20)

Country	Link
US (1)	US4670262A (da)
JP (1)	JPS5978117A (da)
AT (1)	AT382077B (da)
AU (1)	AU559499B2 (da)
BE (1)	BE897761A (da)
CA (1)	CA1211372A (da)
CH (1)	CH655852A5 (da)
DE (1)	DE3333024A1 (da)
DK (1)	DK157168C (da)
FI (1)	FI78236C (da)
FR (1)	FR2533439B1 (da)
GB (1)	GB2127291B (da)
GR (1)	GR79055B (da)
IE (1)	IE56173B1 (da)
IL (1)	IL69752A (da)
IT (1)	IT1153974B (da)
NL (1)	NL8303211A (da)
SE (1)	SE464061B (da)
SU (1)	SU1424722A3 (da)
ZA (1)	ZA836904B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8303657A (nl) *	1983-10-24	1985-05-17	Pharmachemie Bv	Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
ES8801168A1 (es) *	1984-11-02	1987-02-16	Johnson Matthey Plc	Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
JPH0665648B2 (ja) *	1985-09-25	1994-08-24	塩野義製薬株式会社	白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) *	1988-04-18	1996-08-14	マルハ株式会社	脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A7 (fi) *	1988-11-14	1990-05-15	Bristol Myers Squibb Co	Hypertoninen cisplatin-liuos
US20030148933A1 (en) *	1990-10-01	2003-08-07	Pharma Mar S.A.	Derivatives of dehydrodidemnin B
ATE173627T1 (de) *	1992-09-04	1998-12-15	Fuji Chem Ind Co Ltd	Medizinische zusammensetzung
FR2759293B1 (fr) *	1997-02-11	1999-04-30	Ethypharm Lab Prod Ethiques	Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en)	1998-02-18	1998-04-15	Pharma Mar Sa	Pharmaceutical formulation
CZ302498B6 (cs) *	1999-11-15	2011-06-15	Pharma Mar, S. A.	Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
UA76718C2 (uk) *	2000-06-30	2006-09-15	Фарма Мар, С.А.	Протипухлинні похідні аплідину
IL155273A0 (en) *	2000-10-12	2003-11-23	Pharma Mar Sa	Pharmaceutical compositions comprising an aplidine compound
ES2571219T3 (es)	2001-01-25	2024-09-23	The United States Of America Represented By The Sec Dep Of Health And Human Services	Formulación de compuestos de ácido borónico
RU2178702C1 (ru) *	2001-02-21	2002-01-27	Общество с ограниченной ответственностью "Нобель"	Антираковое средство
WO2003026642A1 (en) *	2001-09-21	2003-04-03	Sumitomo Pharmaceuticals Co., Ltd.	Freeze-dried pharmaceutical preparation
DE60229414D1 (de) *	2001-10-19	2008-11-27	Pharma Mar Sa	Verwendung von aplidine in der behandlung von pankreaskrebs
EP1620117A4 (en) *	2003-03-12	2009-07-29	Pharma Mar Sa	IMPROVED ANTITUMORAL TREATMENTS
AU2004218883B2 (en) *	2003-03-12	2009-10-01	Dana-Farber Cancer Institute, Inc.	Aplidine for multiple myeloma treatment
ATE347367T1 (de) *	2003-10-13	2006-12-15	Zoser B Salama	Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
US8436190B2 (en) *	2005-01-14	2013-05-07	Cephalon, Inc.	Bendamustine pharmaceutical compositions
WO2007101235A2 (en) *	2006-02-28	2007-09-07	Pharma Mar, S.A.	Improved antitumoral treatments
AU2008313627A1 (en) *	2007-10-19	2009-04-23	Pharma Mar, S.A.	Improved antitumoral treatments
CA2717409A1 (en) *	2008-03-07	2009-09-11	Pharma Mar, S.A.	Improved anticancer treatments
AR072777A1 (es)	2008-03-26	2010-09-22	Cephalon Inc	Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) *	2008-09-25	2010-04-01	Cephalon, Inc.	Liquid formulations of bendamustine
CN107773538B (zh) *	2016-08-27	2022-09-13	鲁南制药集团股份有限公司	稳定的甲啶铂无菌冻干粉末及其制备工艺
KR102491180B1 (ko)	2017-04-27	2023-01-20	파르마 마르 에스.에이.	항종양 화합물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1432562A (en) *	1972-04-10	1976-04-22	Rustenburg Platinum Mines Ltd	Platinum co-ordination compounds
GB1432563A (en) *	1972-04-10	1976-04-22	Rustenburg Platinum Mines Ltd	Platinum- co-ordination compounds
US4053587A (en) *	1973-04-13	1977-10-11	Research Corporation	Method of treating viral infections
US4255417A (en) *	1976-08-04	1981-03-10	Johnson Matthey, Inc.	Platinum compounds for the irradication of skin blemishes
SE445172B (sv) *	1978-05-30	1986-06-09	Bristol Myers Co	Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) *	1979-08-16	1981-06-16	Mpd Technology Corporation	Preparation of platinum complexes
US4302446A (en) *	1979-10-02	1981-11-24	Bristol-Myers Company	Pharmaceutical compositions
US4451447A (en) *	1980-03-31	1984-05-29	Bristol-Myers Company	Pharmaceutical formulations
AU541056B2 (en) *	1980-03-31	1984-12-13	Bristol-Myers Company	Pharmaceuticals formulations

1982
- 1982-09-23 IT IT23396/82A patent/IT1153974B/it active
1983
- 1983-09-12 GB GB08324380A patent/GB2127291B/en not_active Expired
- 1983-09-13 DE DE3333024A patent/DE3333024A1/de not_active Withdrawn
- 1983-09-13 AT AT0326283A patent/AT382077B/de active
- 1983-09-13 AU AU19089/83A patent/AU559499B2/en not_active Ceased
- 1983-09-13 SE SE8304920A patent/SE464061B/sv not_active IP Right Cessation
- 1983-09-14 JP JP58168513A patent/JPS5978117A/ja active Pending
- 1983-09-15 GR GR72452A patent/GR79055B/el unknown
- 1983-09-15 SU SU833643499A patent/SU1424722A3/ru active
- 1983-09-15 FI FI833300A patent/FI78236C/fi not_active IP Right Cessation
- 1983-09-15 BE BE0/211538A patent/BE897761A/fr not_active IP Right Cessation
- 1983-09-15 CH CH5037/83A patent/CH655852A5/de not_active IP Right Cessation
- 1983-09-16 ZA ZA836904A patent/ZA836904B/xx unknown
- 1983-09-16 NL NL8303211A patent/NL8303211A/nl not_active Application Discontinuation
- 1983-09-16 IL IL69752A patent/IL69752A/xx unknown
- 1983-09-16 IE IE2172/83A patent/IE56173B1/en unknown
- 1983-09-16 DK DK424383A patent/DK157168C/da not_active IP Right Cessation
- 1983-09-16 FR FR8314772A patent/FR2533439B1/fr not_active Expired
- 1983-09-20 CA CA000437117A patent/CA1211372A/en not_active Expired
1985
- 1985-05-28 US US06/738,436 patent/US4670262A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SE8304920D0 (sv)	1983-09-13
GB8324380D0 (en)	1983-10-12
AU1908983A (en)	1984-03-29
DK424383A (da)	1984-03-24
IE832172L (en)	1984-03-23
AT382077B (de)	1987-01-12
IT8223396A0 (it)	1982-09-23
CA1211372A (en)	1986-09-16
IL69752A (en)	1986-07-31
FI833300A7 (fi)	1984-03-24
FI78236B (fi)	1989-03-31
GR79055B (da)	1984-10-02
FI833300A0 (fi)	1983-09-15
FI78236C (fi)	1989-07-10
IT1153974B (it)	1987-01-21
IE56173B1 (en)	1991-05-08
SE8304920L (sv)	1984-03-24
SU1424722A3 (ru)	1988-09-15
US4670262A (en)	1987-06-02
ZA836904B (en)	1984-10-31
FR2533439B1 (fr)	1986-08-14
GB2127291A (en)	1984-04-11
DK424383D0 (da)	1983-09-16
ATA326283A (de)	1986-06-15
IL69752A0 (en)	1983-12-30
FR2533439A1 (fr)	1984-03-30
BE897761A (fr)	1984-01-02
GB2127291B (en)	1986-01-15
AU559499B2 (en)	1987-03-12
JPS5978117A (ja)	1984-05-04
NL8303211A (nl)	1984-04-16
DE3333024A1 (de)	1984-03-29
SE464061B (sv)	1991-03-04
DK157168B (da)	1989-11-20
CH655852A5 (de)	1986-05-30

Legal Events

Date	Code	Title	Description
1994-05-24	PBP	Patent lapsed

Publication	Publication Date	Title
DK157168C (da)	1990-04-09	Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid
DK460283D0 (da)	1983-10-06	Fremgangsmade til fremstilling af topiske farmaceutiske praeparater
DK1183A (da)	1983-07-08	Fremgangsmaade til fremstilling af tiazolidinderivater
DK241883A (da)	1983-12-04	Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK280282A (da)	1982-12-25	Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK372283D0 (da)	1983-08-15	Fremgangsmade til fremstilling af desoxyuridinderivater
DK149899C (da)	1987-05-04	Fremgangsmaade til fremstilling af termohaerdelige formstoffer paa basis af n,n'-diphenylen-bis-maleimider
DK127482A (da)	1982-09-24	Fremgangsmaade til fremstilling af dipeptidforbindelser
DK51282A (da)	1982-08-07	Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK309783A (da)	1984-01-09	Fremgangsmaade til fremstilling af organoglykosider
DK119083D0 (da)	1983-03-14	Fremgangsmade til fremstilling af alkanoylpyridinoner
DK162230C (da)	1992-03-02	Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK424083A (da)	1984-03-29	Fremgangsmaade til fremstilling af anthracyclinglycosider
DK296383A (da)	1983-12-30	Fremgangsmaade til fremstilling af fenaetylaminer
DK34888A (da)	1988-07-28	Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK185683D0 (da)	1983-04-26	Fremgangsmade til fremstilling af pleuromutilinderivater
DK165583D0 (da)	1983-04-15	Fremgangsmade til fremstilling af furanderivater
DK47681A (da)	1981-08-08	Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK475783D0 (da)	1983-10-14	Fremgangsmade til fremstilling af farmaceutiske praeparater
DK436583D0 (da)	1983-09-23	Fremgangsmade til fremstilling af piperidinderivater
DK20983A (da)	1983-07-22	Fremgangsmaade til fremstilling af indolinderivater
DK236683D0 (da)	1983-05-26	Fremgangsmade til fremstilling af trifenylbutenderivater
DK219483A (da)	1983-11-25	Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283D0 (da)	1983-02-11	Fremgangsmade til fremstilling af peptidergotalkaloider
DK9383A (da)	1983-07-13	Fremgangsmaade til fremstilling af phosphinoxider